Disproportionality analyses are a mainstay of pharmacovigilance research, but without clear guidelines, they often lead to confusion and misinterpretation. Enter the READUS-PV statement: the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible. Tune in to find out: The history of reporting guidelines i ... Show More
Nov 21
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing tru ... Show More
29m 9s
Oct 17
#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities, but they have also increased the stakes. How do we use them without ... Show More
29m 1s
Feb 2025
The Truth About Nutrition: How You Can Take a Science-Based Approach | Bradley Johnston PhD
<p>Misinformation in nutrition is rampant. From demonizing red meat to hyping plant-based diets, conflicting advice has left many people confused about what’s truly evidence-based. In this episode, I am joined by Dr. Bradley Johnston<strong>, </strong>an expert in evidence-based ... Show More
1h 30m
Mar 2024
Dr Jelena Vulevic on Delaying Ageing using Prebiotics and Postbiotics
In this revolutionary episode of the Gut Health Gurus Podcast, host Kriben Govender, a renowned Food Scientist and nutritionist, converses with Gut Microbiologist and Microbiome expert Dr Jelena Vulevic on Prebiotic supplementation (Beta GOS), and about her ground breaking resear ... Show More
1h 6m
Aug 20
Why numeracy counts in everyday life, with Ellen Peters, PhD
From deciding whether to buy a house to weighing the risks and benefits of taking a new medication, many important life decisions hinge on understanding numbers, statistics and probability. Ellen Peters, PhD, author of “Innumeracy in the Wild: Misunderstanding and Misusing Number ... Show More
35m 22s
Jan 2024
How Can We Reduce Unnecessary Lab Testing?
Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ... Show More
15m 15s
Sep 24
Teens, AI and the science of risky decisions, with Valerie Reyna, PhD
You might think the best way to make decisions is to know all the facts. But psychologists’ research suggests that getting the “gist” – the core meaning behind the facts – is more important than focusing on every last detail. Valerie Reyna, PhD, talks about why gist matters; how ... Show More
34m 33s
Jun 2020
Covid-19 update: Cardiovascular disease, testing, social distancing and shielding, and dexamethasone
Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ... Show More
11m 12s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. </ ... Show More
30m 11s